Beranda539871 • BOM
add
Thyrocare Technologies Ltd
Tutup sebelumnya
₹1.065,95
Rentang hari
₹1.070,05 - ₹1.101,45
Rentang tahun
₹620,85 - ₹1.101,45
Kapitalisasi pasar
57,98 M INR
Volume Rata-Rata
5,22 rb
Rasio P/E
63,88
Hasil dividen
1,92%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 1,87 M | 21,34% |
Biaya operasional | 602,90 jt | 61,94% |
Laba bersih | 217,00 jt | 22,05% |
Margin laba bersih | 11,59 | 0,52% |
Penghasilan per saham | 4,16 | 17,51% |
EBITDA | 577,45 jt | 82,58% |
Tarif pajak efektif | 54,29% | — |
Neraca
Total aset
Total liabilitas
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 1,92 M | 31,30% |
Total aset | 6,93 M | 7,59% |
Total liabilitas | 1,46 M | 25,33% |
Total ekuitas | 5,47 M | — |
Saham yang beredar | 52,04 jt | — |
Harga terhadap nilai buku | 10,15 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 20,36% | — |
Arus Kas
Perubahan kas bersih
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | 217,00 jt | 22,05% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Didirikan
1996
Kantor pusat
Situs
Karyawan
1.693